Member Info for marik

With certainty - I'm off to the naughty step due to poor grammar.

I think it could be 6pm - what I certainly know is that we are very close.

Looks like sale news could be imminent!

However, my real expectation is around the 237p per share. We should 7 to 10 bag from here onwards. The current share price is so silly, it should be sitting around 55p, with the assumption that no deal would mean we go it ourselves and the price should still settle around 40p.

I'm sure you would snap my hand off LOL. What would you snap off for £5 FSP.

I removed Rhodium from my model because there is a lack of definitive data, but I've done a lot of number crunching and my lower estimate is £1.80.

However, the upper end of the estimation is closer to the £5 mark and assumes that the DFS is very positive. It has the potential to be astronomical.

Tigra, if "Rhodium is substantially adding to the profit at WK", that would mean the estimated deposits are big enough to cause a fluctuation in profits. I agree that the DFS would have the definitive value and it is under wrap. As part of the due diligence I would be very surprised if the buyers didn't do as a thorough an analysis as possible for the in ground metals. In my opinion the time taken to completion is a good sign.

Does anyone have an estimate of the Rhodium deposits?

£5 billion would be my lower estimate and assumes a heavily discounted flanks and neighbouring regions. circa 180p should therefore be the starting point for any negotiations. I can't see it going below this, but you never know.

I need a new F5 button for my keyboard to buy.

I'll register for the 5th of March and a price of 237p

An over engineered blog.

VanV, you are correct regarding the turbulence. There will certainly be some, and it will be down to investor sentiment. HMG plan was always to tout the LFT, it makes a lot of sense, this was something I also picked up on last year. However, i) the LFT rollout will take time, ii) the CEO of Avacta mentioned very clearly that LFT tests can't and will not replace PCR testing, they are less sensitive and effective iii) The amount of testing required is so big, that irrespective the demand on PCR and NCYT will outstrip supply iv) Boris states 75 million tests a week, which is a fantastic figure, but will require some exceptional infrastructure, time and effort to get this rolled out and even then, v) there is a very big demand for PCR.

For this reason, I would argue that the NCYT future is bright, just ride out the very short term turbulence.

Coming to some figures, HMG scientists know that there is no option but to have both PCR and LFT. What is required from NCYT is simply a phase 2 announcement. From my calculations, this could be approaching £2.9 Billion contract over a six month period, for 1000 fully functioning machines (with 300 already in place). The sentiment should return following an announcement like this. With revenue approaching £3.5 Billion, the rerate will be astronomical (assuming no additional buyers come along). The true value when I did a back of envelope was approx. £10.20 per share back in early-Dec.

Fair points VanV. I would like to add that I've heard the CEOs of one of the better lateral flow test manufacturers speaking recently. He is adamant that the two (PCR and LFT) are not to be compared and that PCR will not be replaced by lateral flow testing.

I asked a question about acquisitions and they said they were not taking any questions on M&A.

I hope it is more blue days to come. The last RNS by the management was a bit more convincing.

I've dealt with plenty of Russians and Cypriots, they are not the same as you see in the movies or on the BBC. There is nothing to be afraid of. BoD do say they are carrying out an investigation, but there needs to be an independent investigation into the Board.

I'm trying to understand your logic.

Alexei Churakov was hired as a mining M&A expert and as Strategic Advisor to the board. The "highly respected" Russian ii, bought 27.4 million shares in Eurasia Mining from him and the Board of Directors were blind. Because Alexei didn't advise the board of his sale? The BoD claimed they didn't know and you believe them?

If we assume that the BoD have done nothing wrong, then for certain there a sale of Eurasia to be carried out. But, it doesn't absolve the MM's on this. If however the BoD did know about Alexei selling his shares, then there may not be an acquisition any more. The RNS the BoD put out on Thursday was a no brainer i.e. distance yourselves from Alexei and claim that he acted of his own accord. I find that hard to believe.

It's interesting what can be achieved when many of the little players club together:

https://www.bbc.co.uk/news/business-55843829